Keyphrases
Glycogen Synthase Kinase 3 (GSK3)
100%
Colorectal Cancer
100%
Chemotherapy-induced
100%
Colorectal Cancer Cells
100%
Small Molecule Inhibitors
100%
9-ING-41
100%
Chemotherapy
40%
Cancer Types
20%
Mechanism of Action
20%
Standard of Care
20%
Tumor
20%
Targeted Therapy
20%
High Demand
20%
Growth Inhibition
20%
Transcriptome Analysis
20%
5-fluorouracil (5-FU)
20%
Treatment Standards
20%
Novel Therapies
20%
GSK-3 Inhibitors
20%
Organoid Models
20%
Cell Cycle Arrest
20%
Analysis Support
20%
Pancreatic Cancer Cells
20%
Transcriptome Profile
20%
Molecular Alterations
20%
K-ras
20%
Cancer Resistance
20%
KRAS mutation
20%
DNA Repair Deficiency
20%
Oxaliplatin
20%
Molecular Biomarkers
20%
Colorectal Cancer Cell Lines
20%
Patient-derived Organoids
20%
STK33
20%
New Targeted Therapy
20%
Standard-of-care Therapy
20%
Substantial Similarity
20%
Interesting Points
20%
Medicine and Dentistry
Cancer Cell
100%
Colorectal Cancer
100%
Glycogen Synthase Kinase
100%
Neoplasm
22%
Targeted Therapy
22%
Phosphotransferase
22%
Disease
11%
DNA Repair
11%
Malignant Neoplasm
11%
Growth Inhibition
11%
Biological Marker
11%
Gene Expression Profiling
11%
Transcriptomics
11%
Pancreas Cancer
11%
Cell Cycle Arrest
11%
Ras
11%
Oxaliplatin
11%
Organoid
11%
Colorectal Cancer Cell Line
11%
Drug Resistance
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Colorectal Cancer
100%
Glycogen Synthase Kinase
100%
Phosphotransferase
20%
Neoplasm
20%
Malignant Neoplasm
10%
Biological Marker
10%
Pancreas Cancer
10%
Disease
10%
Oxaliplatin
10%
Drug Resistance
10%